Biomarkers in glioblastoma and degenerative CNS diseases: defining new advances in clinical usefulness and therapeutic molecular target
BackgroundDiscovering biomarkers is central to the research and treatment of degenerative central nervous system (CNS) diseases, playing a crucial role in early diagnosis, disease monitoring, and the development of new treatments, particularly for challenging conditions like degenerative CNS disease...
Saved in:
| Main Authors: | Fan Bu, Jifa Zhong, Ruiqian Guan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Molecular Biosciences |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2025.1506961/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ATRX, OLIG2, MGMT, and IDH2 in Glioblastoma: Essential Molecular Mechanisms and Therapeutic Significance
by: Andrea Pop-Crisan, et al.
Published: (2025-04-01) -
A review of prognostic molecular biomarkers for glioblastoma and their clinical significance for diagnosis and treatment
by: A.M. Netliukh, et al.
Published: (2024-10-01) -
Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions
by: Justin Tang, et al.
Published: (2025-03-01) -
Moesin silencing enhances the radiosensitivity of glioblastoma by inhibiting DNA damage repair via CD44/AKT1 signaling pathway
by: Xin Ding, et al.
Published: (2025-07-01) -
Glioblastoma Multiformе Tumour Stem Cells as Potential Therapeutic Targets
by: O. A. Beylerli, et al.
Published: (2019-11-01)